Free tool
Medicare drug spending
Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
8
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 8 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Pemfexy Pemetrexed · J9304 | B | $58.5M | +6% | 2,819 | $20,745 | $56.43 |
| Alimta* Pemetrexed Disodium* · J9305 | B | $23.0M | -71% | 13,143 | $1,753 | $4.44 |
| Pemetrexed Disodium Pemetrexed Disodium | D | $2.4M | -6% | 411 | $5,750 | $413.77 |
| Alimta Pemetrexed Disodium | D | $728K | -65% | 27 | $26,956 | $1,382.15 |
| Pemetrexed (J9294)* Pemetrexed* · J9294 | B | $617K | -3% | 565 | $1,093 | $3.64 |
| Pemetrexed (J9314) Pemetrexed · J9314 | B | $319K | +135% | 70 | $4,551 | $11.78 |
| Pemetrexed Disodium Pemetrexed Disodium · J9297 | B | $57K | -31% | 206 | $275 | $1.27 |
| Pemetrexed Pemetrexed | D | $29K | n/a | 11 | $2,604 | $201.14 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.